Literature DB >> 15564764

Evolution of renal interstitial inflammation and NF-kappaB activation in spontaneously hypertensive rats.

Bernardo Rodríguez-Iturbe1, Yasmir Quiroz, Atilio Ferrebuz, Gustavo Parra, Nosratola D Vaziri.   

Abstract

Lymphocytes and macrophages infiltrate the kidney of spontaneously hypertensive rats (SHR) and interventions leading to their reduction are associated with improvement of the hypertension. The present studies examined the evolution of the interstitial inflammation in the natural course of the SHR to gain insight on the potential role of interstitial immune cell accumulation in the development of hypertension. We studied SHR and control WKY rats at 3 weeks (SHR-3 wk group, n = 11 and WKY-3 wk group, n = 10), 11 weeks (SHR-11 wk group, n = 5 and WKY-11 wk group, n = 5) and 24 weeks (SHR-24 wk group, n = 10 and WKY-24 wk group, n = 10). The SHR-3 wk group was normotensive and older SHR developed hypertension that was severe in the SHR-24 wk group. Tubulointerstitial accumulation of lymphocytes, macrophages, angiotensin II-positive cells, cells expressing the p65 DNA-binding subunit of NF-kappaB and activation of NF-kappaB in the kidney were all significantly increased (p < 0.01) in the prehypertensive SHR-3 wk group and augmented progressively, with the highest values in the SHR-24 wk group. The SHR-24 wk group showed increased (p < 0.001) helper (CD4) T cell infiltration and a high CD4/CD8 ratio. These findings are consistent with the possibility that activation of NF-kappaB and renal interstitial infiltration of immune cells may be part of the pathophysiologic process that drives hypertension in the SHR. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564764     DOI: 10.1159/000082313

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  41 in total

Review 1.  Dual opposing roles of adaptive immunity in hypertension.

Authors:  Noureddine Idris-Khodja; Muhammad Oneeb Rehman Mian; Pierre Paradis; Ernesto L Schiffrin
Journal:  Eur Heart J       Date:  2014-03-30       Impact factor: 29.983

Review 2.  Monocytes as immune targets in arterial hypertension.

Authors:  Philip Wenzel
Journal:  Br J Pharmacol       Date:  2018-07-14       Impact factor: 8.739

Review 3.  The role of T cells in the pathogenesis of primary hypertension.

Authors:  Yasmir Quiroz; Richard J Johnson; Bernardo Rodríguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2012-10-03       Impact factor: 5.992

Review 4.  The immune system and hypertension.

Authors:  Madhu V Singh; Mark W Chapleau; Sailesh C Harwani; Francois M Abboud
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice.

Authors:  Nosratola D Vaziri; Hyun Ju Kim; Hamid Moradi; Farbod Farmand; Kaveh Navab; Mohamad Navab; Susan Hama; Alan M Fogelman; Yasmir Quiroz; Bernardo Rodriguez-Iturbe
Journal:  Nephrol Dial Transplant       Date:  2010-05-20       Impact factor: 5.992

Review 6.  The immunological basis of hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Héctor Pons; Yasmir Quiroz; Richard J Johnson
Journal:  Am J Hypertens       Date:  2014-08-23       Impact factor: 2.689

Review 7.  Toll-like receptors and hypertension.

Authors:  Madhu V Singh; François M Abboud
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-11       Impact factor: 3.619

8.  Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR.

Authors:  Carrie M Elks; Nithya Mariappan; Masudul Haque; Anuradha Guggilam; Dewan S A Majid; Joseph Francis
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

Review 9.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

10.  TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.